$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
NEW YORK CITY, NY / ACCESSWIRE / October 22, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. ("Novavax" or "the Company") (NASDAQ:N
Novavax, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - NVAX
03:15pm, Monday, 21'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novavax, Inc. ("Novavax, Inc.") (NASDAQ:NVAX) concerning possible violation
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
03:00pm, Monday, 21'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to c
Lost Money on Novavax, Inc. (NVAX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
10:15am, Monday, 21'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novavax, Inc. ("Novavax, Inc.") (NASDAQ:NVAX) concerning possible violation
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
10:06am, Monday, 21'st Oct 2024
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
07:45am, Monday, 21'st Oct 2024
Let's look beyond this piece of bad news from regulators.
NEW YORK--(BUSINESS WIRE)---- $NVAX #Novavax--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or “t
Lost Money on Novavax, Inc.(NVAX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
03:01pm, Sunday, 20'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Novavax, Inc. ("Novavax, Inc.") (NASDAQ:NVAX) concerning possible violation
NEW YORK CITY, NY / ACCESSWIRE / October 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. ("Novavax" or "the Company") (NASDAQ:N
How Bad Is This News for Novavax?
06:15pm, Saturday, 19'th Oct 2024
Novavax stock fell 20% in one trading session on the news.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
12:00pm, Saturday, 19'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX). Such investors are advised to c
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX
09:43pm, Thursday, 17'th Oct 2024
NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX). Such investors are advised to contac
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
06:51pm, Thursday, 17'th Oct 2024
Novavax (NVAX) closed at $10.35 in the latest trading session, marking a +1.97% move from the prior day.
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
09:15am, Thursday, 17'th Oct 2024
NVAX's COVID-19-flu combination and stand-alone flu vaccines have been placed on hold after a study participant who took the combo shot reported nerve damage.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Novavax, Inc. (NVAX) And Encourages Stockholders to Connect
06:00pm, Wednesday, 16'th Oct 2024
NEW YORK CITY, NY / ACCESSWIRE / October 16, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. ("Novavax" or "the Company") (NASDAQ:N
Sign In
Buy NVAX